Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

NuvaRing trial dates set for early 2013 in New Jersey state court

Filed March 30th, 2012 Joshua Sophy

A New Jersey state court judge presiding over Mass Tort litigation of lawsuits alleging serious injuries from use of the NuvaRing contraceptive.

There have been more than a thousand NuvaRing injury lawsuits filed in state and federal courts across the country. According to a recent release, Judge Brian Martinotti in Bergen County Superior Court has set Feb. 4, 2013, as the projected start date for the first of eight bellwether trials among the 125 cases included in the state Mass Tort.

Another 850 or more NuvaRing lawsuits have been consolidated as part of federal Multidistrict Litigation in U.S. District Court for the Eastern District of Missouri.

Among the hundreds of lawsuits is a common theme. Women prescribed the non-traditional contraceptive method which uses hormone therapy delivered through a vaginally-inserted ring device contend NuvaRing is responsible for them suffering any number of serious side effects, including blood clots, stroke and pulmonary embolism. Some deaths have been attributed to these side effects caused by NuvaRing, which is manufactured by the firm Organon.

A 2003 study linked use of low-doses of one of the two hormones found in NuvaRing, progestin desogestrel, with an increased risk of thromboembolism, which is a life-threatening form of blood clot.

The Food and Drug Administration has been petitioned to ban NuvaRing by the watchdog group Public Citizen because of its apparent high risk of these side effects, especially when methods of prescription contraceptives are available that don’t present these side effects.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!